{
    "nct_id": "NCT06534125",
    "official_title": "Preventing Aromatase Inhibitor-Associated Arthralgias Among Non-Hispanic Black Postmenopausal Women with Early-Stage Breast Cancer",
    "inclusion_criteria": "* Age â‰¥ 18 years\n* Self-identified Non-Hispanic Black woman\n* Postmenopausal status (>= 12 months since last menstrual period, history of bilateral salpingo-oophorectomy, or estradiol, follicle-stimulating hormone [FSH], and luteinizing hormone [LH] levels consistent with menopause)\n* Diagnosed with stage I-III HR+/HER2 negative (-) breast cancer\n* Completed all phases of active therapy (e.g. surgery, chemotherapy, and/or radiation) at least 14 days before study enrollment\n* Planned to start adjuvant AI\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnosed with metastatic breast cancer\n* Premenopausal status\n* History of allergic reactions attributed to compounds of similar chemical or biologic composition to acupuncture needles or other agents used in study\n* Diagnosis of rheumatoid arthritis, multiple sclerosis, or muscular dystrophy\n* A history of or current CDK 4/6 inhibitor use\n* A history of neoadjuvant AI use\n* Use of adjuvant AI > 14 days\n* Received acupuncture within 60 days prior to start of study",
    "miscellaneous_criteria": ""
}